ActiGraft® System


Recreating the Natural Wound Healing Environment

 ActiGraft, based on RedDress’ proprietary patented technology, is a FDA-cleared wound care solution that enables health care providers to produce—in real time—in vitro blood clots from a patient’s whole blood. Once applied, the autologous blood clot serves as a protective covering and supports wound healing processes which naturally occur in the patient's body.

See How ActiGraft Works →
Faster Application

Faster Coagulation

Can be prepared at the patient’s bedside in 12 minutes*

*Full procedure and application times may vary

Cost Effective Treatment

Cost Effective Treatment

Provides significant savings in nursing costs and simplifies wound treatment

Patient Comfort

Patient Comfort

Fast healing with less wound interaction

Easy Integration

Continuum of Care

Seamlessly integrates into current chronic wound treatment practices

Simplified Process

Elegant Process

Enables healthcare providers to efficiently execute ongoing wound treatment

Supports Natural Healing

Supports Natural Healing

Uses the patient’s own blood to support the body’s own healing processes

Take the Guessing Out of Wound Management

Standard of Care topical dressings address one or two aspects of a chronic wound bed. The ActiGraft dressing contains the fibrin matrix (derived from the patient's own blood) acting to support the body's own wound healing processes.

ActiGraft changes the way we treat chronic wounds by supporting every stage of the wound healing process and taking the guesswork out of wound treatment.

See How ActiGraft Works →
ActiGraft dressing

ActiGraft Procedure


Efficient Wound Treatment

  • Provides the wound with an optimal, natural healing environment, allowing the healing process to proceed unhindered.
  • Weekly vs. daily ActiGraft application saves facility staff nursing time.
  • Published results of 72% complete healing within 12 weeks.2,3,4

Simplified Procedures

  • Single-use, state-of-the-art, autologous graft wound care solution.
  • Designed with healthcare providers in mind, ActiGraft can be prepared at the patient's bedside in 12 minutes.
  • Ready to use right out of the box. Eliminates need for complex processing, temperature monitoring or storage (ActiGraft requires ambient temperature storage conditions).

Reduced Costs

  • Because ActiGraft uses the patient’s own blood, we aren’t required to register as a tissue donor bank or go through the regulatory recording processes of skin substitutes. This reduces administration and documentation requirements.
  • No capital equipment requirements.
  • Reduced costs compared to other chronic wound treatments.

Increased Patient Safety and Comfort

  • Autologous blood clot allows the body’s natural wound healing processes to operate.
  • Fast healing with less wound interaction.
  • Patients have reported improved quality of life. 

ActiGraft Uses

ActiGraft can be used for a wide variety of hard-to-treat chronic wounds, including but not limited to:

  • Diabetic/Neuropathic ulcers
  • Pressure Ulcers/Injury
  • Venous Stasis Ulcers
  • Surgical Debridement wounds
  • Traumatic wounds
  • Skin Tears


ActiGraft is contraindicated in patients with the following types of wounds:

  • Wounds due to malignancy
  • Wounds with active clinically diagnosed infection

Technical Specs

  • Radius of ActiGraft clot – 3cm (Diameter 6sq cm)
  • Clot size: 28.3sq cm
  • 20ml of blood required
  • Storage conditions - Store in the original container at a room temperature of 5°C (41°F) – 30°C (86°F). Protect from freezing and avoid excessive heat.

Interested in Introducing ActiGraft
into your Practice?

ActiGraft® Virtual Training is a quick and easy program designed to fit your busy schedule. Begin treating patients immediately within your health care setting.

Learn More →
This product may be protected by one or more patents. For further information please visit: